within Pharmacolibrary.Drugs.V_Various.V09D_HepaticAndReticuloEndothelialSystem.V09DA01_Technetium99mtcDisofenin;

model Technetium99mtcDisofenin
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C(
    weight = 70,
    F = 1,
    Cl = 1.1666666666666666e-05,
    adminDuration = 600,
    adminMass = 185 / 1000000,
    adminCount = 1,
    Vd = 0.00016,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Technetium99mtcDisofenin</td></tr><tr><td>ATC code:</td><td>V09DA01</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>185</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.16</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.6</td><td>L/h/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Technetium (99mTc) disofenin is a radiopharmaceutical agent used in hepatobiliary imaging to evaluate liver and gallbladder function. It is administered intravenously and taken up by hepatocytes, then excreted in the bile. It is approved and currently used for diagnostic imaging in nuclear medicine.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for intravenous use in adult subjects based on general radiopharmaceutical properties and available labeling information. No compartmental PK model studies or primary human PK data are available.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.V.V09DA01 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Technetium99mtcDisofenin;
